BioNTech with figures: Forecasts beaten - | the details:

0 1

deraktionaer.de/artikel/indizes/dax-prognose-tiefer-us-midterms-bayer-lufthansa-fmc-biontech-amd-apple-palantir-im-fokus-20431435.html

Credibility C

Nov 03

DAX Forecast: Lower - | US Midterms, Bayer, Lufthansa, FMC, BioNTech, AMD, Apple, Palantir in Focus

deraktionaer.de/artikel/deraktionaerplus/biontech-aktie-ueberraschende-absage-neue-details--20417497.html

Oct 15

BioNTech stock: Surprising cancellation - | new details

Paid articlePaywall

BioNTech stock: Surprising cancellation - | new details: BioNTech closes its Tübingen mRNA plant despite a multi-million euro offer. Why the talks ultimately ...

deraktionaer.de/artikel/aktien/bernd-foertsch-ueber-biontech-ruecktritt-ist-ueberfaellig-20409989.html

Oct 01

Bernd Förtsch on BioNTech: Resignation is overdue: Shareholder Bernd Förtsch sharply criticizes the events at the Corona superstar.

deraktionaer.de/artikel/pharma-biotech/moderna-aktie-kennt-kein-halten-mehr-was-ist-mit-biontech-los-20409301.html

Sep 23

Moderna stock knows no bounds - | what's going on with BioNTech?: The stock has roughly tripled since the positive data was released.

deraktionaer.de/artikel/pharma-biotech/nach-moderna-erfolg-blick-richtet-sich-auf-biontech-das-ist-jetzt-geplant-20407208.html

Aug 21

After Moderna's success: Attention turns to BioNTech - | this is what's planned now

5 similar articles

Manager Magazin

Aug 04

Forecast lowered: Vaccine stockpiles full in Germany, BioNTech deep in the red: Weak demand for the Covid-19 vaccine has resulted in significant losses and a ...

manager-magazin.de/unternehmen/pharma/biontech-umsatzprognose-gesenkt-wegen-voller-impfstofflager-a-f3f45a40-8696-4407-8f52-03a4cf7a3981

boerse-online.de/nachrichten/aktien/biontech-auf-neustart-kurs-radikaler-schnitt-mit-ungewissem-ausgang-20404154.html

BÖRSE ONLINE

Jul 06

BioNTech on a restart course: Radical cut with an uncertain outcome: BioNTech has apparently already held confidential talks with interested parties about the ...

manager-magazin.de/unternehmen/pharma/moderna-prueft-kauf-von-biontech-werken-a-5b02be64-8b5b-4ab0-bb1c-c0c8c5e93a7e

Manager Magazin

Jun 17

Vaccine manufacturer: Moderna considers buying Biontech plants: The US pharmaceutical company Moderna is interested in plants in Germany that its competitor ...

2 similar articles

Mittelhessen

Jun 03

DGB plans solidarity campaign with BioNTech employees in Marburg: Layoffs threaten the future of over 500 BioNTech employees in Marburg. The DGB Central Hesse ...

mittelhessen.de/lokales/kreis-marburg-biedenkopf/marburg/dgb-plant-solidarisierungsaktion-mit-biontech-mitarbeitern-5750215

deraktionaer.de/artikel/indizes/iran-krieg-dax-tiefer-oel-hoch-rheinmetall-sap-basf-dhl-biontech-fmc-paypal-amd-im-fokus-20400280.html

May 05

Iran War: DAX lower, oil higher - | Rheinmetall, SAP, BASF, DHL, BioNTech, FMC, PayPal, AMD in focus

mittelhessen.de/lokales/kreis-marburg-biedenkopf/marburg/biontech-sagt-expansion-in-marburg-ab-5457146

Mittelhessen

Mar 01

Paid articlePaywall

Biontech cancels expansion in Marburg: It concerns the development of the "Görzhausen III" industrial park in Marburg: The pharmaceutical company Biontech no ...

deraktionaer.de/artikel/pharma-biotech/biontech-verklagt-moderna-die-details-20395822.html

Feb 20

BioNTech sues Moderna - | the details: BioNTech sues Moderna for patent infringement; shares of both companies remain stable.

op-marburg.de/wirtschaft/regional/marburg-biontech-gsk-und-siemens-healthineers-so-steht-es-um-andere-pharmafirmen-am-standort-4RBRJV7HOJEEVM4ZQNEKP5OTEM.html

Oberhessische Presse

Feb 12

Marburg: BioNTech, GSK, and Siemens Healthineers - | the situation at other pharmaceutical companies at the Behringwerke site

boerse-online.de/nachrichten/fonds/biontech-und-nvidia-aktien-verkauft-medline-und-alphabet-rein-erste-13f-filings-sind-da-20394747.html

BÖRSE ONLINE

Feb 04

BioNTech | and Nvidia shares sold, Medline and Alphabet in: First 13F filings are in!

boerse-online.de/nachrichten/aktien/biontech-aktie-die-hoffnung-ist-zurueck-20392023.html

BÖRSE ONLINE

Dec 15 25

BioNTech stock: Hope is back: BioNTech acquires CureVac and strengthens market position; blockbuster potential for new cancer drug BNT327.

handelsblatt.com/unternehmen/industrie/pharmaindustrie-biontech-halbiert-verlust-krebsstrategie-nimmt-fahrt-auf/100146054.html

Handelsblatt

B+

Aug 04 25

Pharma industry: Biontech halves loss - cancer strategy picks up speed: Biontech more than doubled its turnover in the second quarter. The company plans to spend ...

Key FactsBiontech Boosts Growth with Cancer Strategy and Deals

Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: handelsblatt.com

Biontech doubled its revenue to €260.8 million in Q2 and reduced its net loss to €386.6 million.

The company is refocusing on oncology, strengthened by a partnership with Bristol Myers Squibb and the planned acquisition of Curevac.

Over 20 studies involving BNT327 across various tumors are underway, with a pivotal breast cancer phase-3 study starting this year.

Revenue is forecasted to decline in 2025 while R&D spending is expected to increase to as much as €2.8 billion.

We continue to invest significantly in the implementation of our strategy, and our operational and financial measures are showing initial tangible results.
— CFO Ramón Zapata discusses Biontech's progress in cancer research.

7 similar articles

127

Euronews

Aug 06 25

Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat: Pfizer beat earnings expectations and improved its outlook for the rest of the year ...

Jun 04 25

Buy, sell, or hold BioNTech shares? Price high due to cancer drug: During the coronavirus crisis, BioNTech shares were in huge demand. The results are sobering ...

capital.de/geld-versicherungen/biontech-aktie-kaufen--verkaufen--halten--kurshoch-wegen-krebsmedikament-35776552.html